Helmholtz Association

14.11.2008 Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch

For the first time in a clinical study, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and the Charité - Universitätsmedizin Berlin, Germany, have tested a new technology enabling them to transfer genetic material directly into a tumor by means of high pressure. As Assistant Professors Wolfgang Walther, together with Professor Peter M. Schlag report in Clinical Cancer Research (Vol. 14, Nr. 22, pp. 7545-7553)*, their results show that jet injection delivers genes into the tumor tissue safely and in a targeted manner. The application was well tolerated by all 17 patients enrolled in this study. No adverse events were experienced.

“Jet Injection” for Gene Therapy – First Clinical Trial Evaluates Feasibility

For the first time in a clinical study, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and the Charité - Universitätsmedizin Berlin, Germany, have tested a new technology enabling them to transfer genetic material directly into a tumor by means of high pressure. As Assistant Professors Wolfgang Walther, together with Professor Peter M. Schlag report in Clinical Cancer Research (Vol. 14, Nr. 22, pp. 7545-7553)*, their results show that jet injection delivers genes into the tumor tissue safely and in a targeted manner. The application was well tolerated by all 17 patients enrolled in this study. No adverse events were experienced.

Link
more Information

back to the list

13.01.2013

Contact


There are no results to your query